The following documents have been filed with the SEC:
SEC Filing Alert
10-Q: Quarterly report pursuant to Section 13 or 15(d)
HTML
PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
Relmada Therapeutics, Inc.880 Third Avenue, 12th Floor, New York, NY 10022 United States of America
https://www.relmada.com